Valuation: DexCom, Inc.

Market Cap 28.18B 24.65B 22.73B 21.03B 39.92B 2,689B 40.59B 272B 107B 1,321B 106B 103B 4,575B P/E 2026 *
29.8x
P/E 2027 * 25x
Enterprise Value 27.77B 24.29B 22.4B 20.73B 39.34B 2,651B 40B 268B 105B 1,302B 104B 102B 4,509B EV / Sales 2026 *
5.32x
EV / Sales 2027 * 4.63x
Free-Float
93.34%
Yield 2026 *
-
Yield 2027 * -
1 day-1.40%
1 week+2.48%
Current month+8.42%
1 month-6.61%
3 months+11.18%
6 months+8.34%
Current year+10.02%
1 week 69.74
Extreme 69.74
74.39
1 month 67.3
Extreme 67.3
76.25
Current year 56.72
Extreme 56.72
78.91
1 year 54.11
Extreme 54.11
89.98
3 years 54.11
Extreme 54.11
142
5 years 54.11
Extreme 54.11
164.86
10 years 10.66
Extreme 10.655
164.86
Manager TitleAgeSince
Chief Executive Officer 47 01/01/2026
Director of Finance/CFO 46 19/03/2021
Chief Tech/Sci/R&D Officer - 01/05/2024
Director TitleAgeSince
Chairman 68 30/07/2018
Director/Board Member 67 20/11/2009
Director/Board Member 47 01/01/2026
Date Insider Type Main position Quantity % Market Cap.
07-06Sell

Chairman

-26,756 0.0069%
06-15Sell

General Counsel

-1,700 0.0004%
06-15Sell

Director

-4,000 0.0010%
Change 5-day change 1-year change 3-year change Capi.($)
-1.40%+2.48%-13.96%-42.37% 28.58B
-0.82%-1.05%-29.14%-11.24% 166B
+0.46%-0.96%-7.43%-4.07% 105B
-2.30%+2.01%+0.77%+58.47% 60.23B
+0.46%-3.93%+40.10%+55.44% 49.17B
+0.19%-4.57%-14.05%-41.29% 41.49B
+1.36%-5.42% - - 34.08B
+1.13%-2.21%+58.13%-3.75% 24.99B
-0.99%-2.26%-9.86%+2.75% 20.64B
+3.11%-1.01%-6.61%-0.85% 20.42B
Average +0.13%-0.84%+1.99%+1.45% 55.04B
Weighted average by Cap. -0.21%-0.91%-6.70%+1.90%

Financials

2026 *2027 *
Net sales 5.22B 4.57B 4.21B 3.9B 7.4B 499B 7.53B 50.48B 19.79B 245B 19.61B 19.19B 848B 5.83B 5.1B 4.7B 4.35B 8.25B 556B 8.39B 56.28B 22.06B 273B 21.87B 21.4B 946B
Net income 963M 842M 777M 718M 1.36B 91.88B 1.39B 9.3B 3.65B 45.12B 3.61B 3.54B 156B 1.16B 1.01B 934M 864M 1.64B 111B 1.67B 11.18B 4.38B 54.27B 4.35B 4.25B 188B
Net Debt -405M -354M -327M -302M -574M -38.66B -583M -3.91B -1.53B -18.99B -1.52B -1.49B -65.76B -1.21B -1.06B -977M -904M -1.72B -116B -1.74B -11.7B -4.59B -56.78B -4.55B -4.45B -197B
Logo DexCom, Inc.
DexCom, Inc. specializes in the design, manufacture and marketing of continuous glucose monitoring (CGM) systems for people with diabetes and healthcare providers. The company provides an implantable device for continuous measurement of blood glucose levels and an external transmitter to which the sensor transmits glucose levels at specified intervals. The United States accounts for 71.5% of net sales.
Employees
11,050
Date Price Change Volume
09/07/26 US$73.02 -1.40% 4,163,413
08/07/26 US$74.06 +0.67% 5,338,782
07/07/26 US$73.57 +1.64% 5,569,382
06/07/26 US$72.38 +1.59% 4,621,632
02/07/26 US$71.25 +3.47% 3,299,278
Trader
Investor
Global
Quality
ESG MSCI
BBB
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
28
Last Close Price
73.02USD
Average target price
85.24USD
Spread / Average Target
+16.74%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. DXCM Stock